E B Yalcin1, M Tong1, S M de la Monte1,2. 1. Liver Research Center, Division of Gastroenterology and Department of Medicine, Rhode Island Hospital and the Alpert Medical School of Brown University, USA. 2. Departments of Neurology, Neurosurgery and Pathology, Rhode Island Hospital and the Alpert Medical School of Brown University, USA.
Abstract
BACKGROUND: Chronic feeding plus binge administration of ethanol causes very high blood alcohol concentrations. However, its co-administration with tobacco Nicotine-Derived Nitrosamine Ketone (NNK) results in somewhat lower blood alcohol levels, suggesting that NNK and therefore smoking, alters alcohol metabolism in the liver. To explore this hypothesis, we examined effects of ethanol and/or NNK exposures on the expression and activity levels of enzymes that regulate their metabolism in liver. METHODS: This study utilized a 4-way model in which Long Evans rats were fed liquid diets containing 0% or 26% ethanol for 8 weeks, and respectively i.p injected with saline or 2 g/kg of ethanol 3 times/week during Weeks 7 and 8. The control and ethanol-exposed groups were each sub-divided and further i.p treated with 2 mg/kg of NNK or saline (3×/week) in Weeks 3-8. ADH, catalase and ALDH activities were measured using commercial kits. CYP450 mRNA levels (17 isoforms) were measured by qRT-PCR analysis. RESULTS: Ethanol significantly increased hepatic ADH but not catalase or ALDH activity. NNK had no effect on ADH, ALDH, or catalase, but when combined with ethanol, it increased ADH activity above the levels measured in all other groups. Ethanol increased CYP2C7, while NNK increased CYP2B1 and CYP4A1mRNA levels relative to control. In contrast, dual ethanol + NNK exposures inhibited CYP2B1 and CYP4A1 expression relative to NNK. Conclusion: Dual exposures to ethanol and NNK increase hepatic ethanol metabolism, and ethanol and/or NNK exposures alter the expression of CYP450 isoforms that are utilized in NNK and fatty acid metabolism.
BACKGROUND: Chronic feeding plus binge administration of ethanol causes very high blood alcohol concentrations. However, its co-administration with tobacco Nicotine-Derived Nitrosamine Ketone (NNK) results in somewhat lower blood alcohol levels, suggesting that NNK and therefore smoking, alters alcohol metabolism in the liver. To explore this hypothesis, we examined effects of ethanol and/or NNK exposures on the expression and activity levels of enzymes that regulate their metabolism in liver. METHODS: This study utilized a 4-way model in which Long Evans rats were fed liquid diets containing 0% or 26% ethanol for 8 weeks, and respectively i.p injected with saline or 2 g/kg of ethanol 3 times/week during Weeks 7 and 8. The control and ethanol-exposed groups were each sub-divided and further i.p treated with 2 mg/kg of NNK or saline (3×/week) in Weeks 3-8. ADH, catalase and ALDH activities were measured using commercial kits. CYP450 mRNA levels (17 isoforms) were measured by qRT-PCR analysis. RESULTS: Ethanol significantly increased hepatic ADH but not catalase or ALDH activity. NNK had no effect on ADH, ALDH, or catalase, but when combined with ethanol, it increased ADH activity above the levels measured in all other groups. Ethanol increased CYP2C7, while NNK increased CYP2B1 and CYP4A1mRNA levels relative to control. In contrast, dual ethanol + NNK exposures inhibited CYP2B1 and CYP4A1 expression relative to NNK. Conclusion: Dual exposures to ethanol and NNK increase hepatic ethanol metabolism, and ethanol and/or NNK exposures alter the expression of CYP450 isoforms that are utilized in NNK and fatty acid metabolism.
Authors: Devanshi Seth; Paul S Haber; Wing-Kin Syn; Anna Mae Diehl; Christopher P Day Journal: J Gastroenterol Hepatol Date: 2011-07 Impact factor: 4.029
Authors: Lorenzo Azzalini; Elisabet Ferrer; Leandra N Ramalho; Montserrat Moreno; Marlene Domínguez; Jordi Colmenero; Víctor I Peinado; Joan A Barberà; Vicente Arroyo; Pere Ginès; Joan Caballería; Ramón Bataller Journal: Hepatology Date: 2010-05 Impact factor: 17.425
Authors: Ming Tong; Rosa Yu; Elizabeth Silbermann; Valerie Zabala; Chetram Deochand; Suzanne M de la Monte Journal: Alcohol Alcohol Date: 2015-09-15 Impact factor: 2.826
Authors: Silvia Balbo; Mia Hashibe; Sarolta Gundy; Paul Brennan; Cristina Canova; Lorenzo Simonato; Franco Merletti; Lorenzo Richiardi; Antonio Agudo; Xavier Castellsagué; Ariana Znaor; Renato Talamini; Vladimir Bencko; Ivana Holcátová; Mingyao Wang; Stephen S Hecht; Paolo Boffetta Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-11 Impact factor: 4.254
Authors: James P Hardwick; Douglas Osei-Hyiaman; Homer Wiland; Mohamed A Abdelmegeed; Byoung-Joon Song Journal: PPAR Res Date: 2010-03-16 Impact factor: 4.964